drugset / Trial / NCT01734772

Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor

NCT01734772

Phase 1 Completed 48 enrolled Boehringer Ingelheim
Non-randomizedCrossoverOpen-labelTreatment

Summary

To investigate the pharmacokinetic and pharmacodynamic interaction of dabigatran and ticagrelor under steady state conditions; to investigate the effect of staggered administration of ticagrelor loading dose on dabigatran exposure (in Part II)

Timeline

Start
2012-11
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dabigatran etexilate Unknown
Subject Ticagrelor Small molecule

Indications

No indication recorded.